Long lasting changes in the strength of synaptic transmission in the hippocampus are thought to underlie certain forms of learning and memory. Accordingly, the molecular mechanisms that account for these changes are heavily studied. Postsynaptically, changes in synaptic strength can occur by altering the amount of neurotransmitter receptors at the synapse or by altering the functional properties of synaptic receptors. In this study, we examined the biochemical changes produced following chemically induced long term depression in acute hippocampal CA1 minislices. Using three independent methods, we found that this treatment did not lead to an internalization of ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Furthermore, when the plasma membrane was separated into synaptic membrane-enriched and extrasynaptic membrane-enriched fractions, we actually observed a significant increase in the concentration of AMPA receptors at the synapse. However, phosphorylation of Ser-845 on the AMPA receptor subunit GluR1 was significantly decreased throughout the neuron, including in the synaptic membrane-enriched fraction. In addition, phosphorylation of Ser-831 on GluR1 was decreased specifically in the synaptic membrane-enriched fraction. Phosphorylation of these residues has been demonstrated to control AMPA receptor function. From these data, we conclude that the decrease in synaptic strength is likely the result of a change in the functional properties of AMPA receptors at the synapse and not a decrease in the amount of synaptic receptors.
Rapid excitatory synaptic transmission in the hippocampus is mediated predominantly by glutamate-activated AMPA 2 receptors (AMPARs). Theoretically, long term changes in the strength of synaptic transmission, as occur during long term potentiation and long term depression (LTD), can arise from changes in the amount of glutamate that is released from the presynaptic terminal, changes in the number of synaptic AMPARs, or changes in the functional properties of synaptic AMPARs. Experimentally, LTD of synaptic responses has been shown to be induced by several different treatments, the most common of which include several low frequency stimulation (LFS) paradigms (1) , N-methyl-D-aspartate (NMDA) application (2), 3,5-dihydroxyphenylglycine application (3, 4) , and insulin application (5) . The biochemical mechanisms that underlie these different types of synaptic depression have been the subject of numerous studies in many different experimental systems.
A number of studies have demonstrated that protein phosphatase activity is a requirement for long term depression. This was originally demonstrated through the use of protein phosphatase 1 (PP1), 2A (PP2A), and 2B (PP2B/calcineurin) inhibitors, which were shown to inhibit both the induction and the maintenance of LTD (6, 7) . Furthermore, it has been suggested that synaptically localized PP1 is critical for the induction of LTD and that enhancing the synaptic targeting of PP1 facilitates long term depression (8) . In addition, activation of protein kinase A inhibits the induction of LFS and NMDA-induced LTD, and protein kinase A inhibition has been shown to result in a rundown of synaptic responses that occludes subsequent LTD (9) . The translocation of protein kinase A away from synaptic substrates may be an important step in LTD because NMDA-induced depression has been correlated with a redistribution of the kinase away from the synapse (10, 11) , and disrupting the binding of protein kinase A to one of its anchoring proteins causes synaptic response rundown (12) that occludes induced synaptic depression (10) . Importantly, one of the substrates being dephosphorylated during synaptic depression appears to be the AMPAR. Several groups using different LTD induction protocols and experimental systems have reported decreases in the phosphorylation of GluR1 Ser-845, which is a protein kinase A substrate (2, 8, 11, 13, 14) . Furthermore, mice in which Ser-845 has been mutated to alanine have deficits in long term depression (15) . The mechanisms by which Ser-845 dephosphorylation may contribute to LTD are unknown, but two principal hypotheses have been presented and are discussed below.
Phosphorylation of Ser-845 is known to influence AMPAR functional properties (16) . Specifically, phosphorylation of this residue has been demonstrated to control peak open probability of GluR1-containing receptors (17) . Because of this, several researchers have postulated that a decrease in AMPAR function as the result of Ser-845 dephosphorylation may play a major role in the depression of synaptic responses (18) . However, a key issue for this model is whether the stoichiometry of Ser-845 phosphorylation is decreased on synaptic receptors following LTD induction.
Another postsynaptic mechanism suggested by many to be involved in synaptic depression is the internalization of AMPARs. A role for endocytic processes in general for LTD is provided by studies that have shown that inhibitors of clathrin mediated endocytosis prevent LTD induction (5, 19 -21) . There have also been many studies using cultured neurons that have directly demonstrated AMPAR internalization following LTD-inducing treatments (8, 10, 14, 15, 19, (21) (22) (23) (24) (25) (26) (27) . Furthermore, some LTD studies have demonstrated a reduction in surface AMPARs in the more physiologically relevant acute hippocampal slice system (11, 28 -31) and in vivo (32) . Interestingly, several of these studies have found a correlation between the dephosphorylation of GluR1 Ser-845 and AMPAR endocytosis in cultured neurons (14, 15, 24, 25) and in hippocampal slices (11) , suggesting a role for this phosphorylation site in AMPAR trafficking. However, to date, there is no known mechanism by which Ser-845 might influence trafficking as this site is not part of any known endocytic motifs. In the present report, we have attempted to explore these two hypotheses by directly examining AMPAR phosphorylation and localization following chemical induction of LTD.
EXPERIMENTAL PROCEDURES
CA1 Minislice Preparation and Treatment-All of the experiments used in this study were approved by the Institutional Animal Care and Use Committee at the University of Colorado Health Sciences Center. Twenty-one-(P21) to twenty-nine-(P29) day-old male Sprague-Dawley rats were used for all experiments. After sacrifice, the brain was immediately removed and placed in ice-cold oxygenated artificial cerebrospinal fluid (ACSF: 124 mM NaCl, 4 mM KCl, 1 mM MgCl 2 , 2.5 mM CaCl 2 , 10 mM dextrose, 1 mM KH 2 PO 4 , 25.7 mM NaHCO 3 ). Both hippocampi were carefully dissected out and unrolled along the hippocampal fissure. Subsequently, area CA1 was isolated by two cuts and then sliced into 400-m minislices using a McIlwain tissue chopper. On average, 27 minislices could be harvested from each animal. For all of the electrophysiology experiments and some of the biochemistry experiments, the minislices were transferred to chambers perfused with 32°C ACSF that was bubbled with a 95% O 2 , 5% CO 2 mix. The perfusion rate in these chambers was 3 ml/min. For the remainder of the biochemistry experiments, the minislices were transferred to static chambers and incubated at interface in 32°C ACSF (which had been bubbled with a 95% O 2 , 5% CO 2 mix) and humidified with 95% O 2 , 5% CO 2 . For both setups, minislices were recovered in ACSF for at least 90 min before treatment or recording, with ACSF being changed every 15 min in the static chambers. To induce cLTD in the perfused chambers, NMDA was perfused over the slices at a final concentration of 20 M for 3 min. To induce cLTD in the interface chambers, the ACSF was replaced with ACSF containing 20 M NMDA for 3 min. After 3 min, the NMDA ACSF was replaced with regular ACSF. The control treatment for these experiments was ACSF containing vehicle (H 2 0).
Electrophysiology-Each n for the electrophysiology experiments represents data obtained from one minislice. Field excitatory postsynaptic potentials (fEPSPs) were evoked by stimulating the Schafer collateral-commissural pathway using a bipolar tungsten electrode. A silver chloride recording electrode inside a finely drawn glass capillary containing ACSF was placed in the dendritic layer of the minislice. Both the amplitude and the initial slope of the fEPSP were recorded at the frequency of 0.033 Hz. The stimulus intensity was adjusted to produce a fEPSP with 50 -70% of the maximum achievable response. Following the recording of a stable baseline (at least 20 min), cLTD was induced (as described above). The stimulator was turned off during the treatment and the washout of the NMDA to ensure that depression was not dependent on electrical stimulation. Depression (percent change) at 45 min following the termination of the cLTD treatment was calculated by comparing the average of the responses recorded from 40 -50 min following the termination of the treatment to the average of the responses recorded 10 min immediately prior to the treatment.
Subcellular Fractionation-For experiments in which the lysed crude synaptosomal membrane fraction (LP1) was collected, each n represents all of the minislices that could be harvested from one animal divided equally between control and cLTD conditions. For experiments in which the postsynaptic density (PSD)/synaptic membrane-enriched fraction (TxP) was collected, each n represents all of the minislices that could be harvested from two animals divided equally between control and cLTD conditions (the pooling of animals was required to ensure that each fraction contained a sufficient amount of protein for analysis). In both cases, minislices were harvested 45 min after the treatment into ice-cold homogenization buffer containing 320 mM sucrose, 10 mM Tris (pH 7.4), 100 M Na 3 VO 4 , 40 mM NaF, 300 nM okadaic acid, and 1 mM EDTA. Following harvesting, the slices were immediately homogenized in a glass grinding vessel by a Teflon pestle rotating at 1000 rpm. Subsequently, a subcellular fractionation protocol was employed (11, (33) (34) (35) (36) . The homogenate was spun at 1000 ϫ g for 10 min, and the pellet (P1), which contains nuclei and incompletely homogenized material, was discarded. The supernatant (S1) was then spun at 10,000 ϫ g for 15 min. For the LP1 experiments, the pellet from this spin (P2) was resuspended in homogenization buffer lacking sucrose and hypoosmotically lysed for 30 min on ice. The lysed P2 was then respun at 10,000 ϫ g for 15 min, and the resulting pellet, LP1 (lysed crude synaptosomal membrane fraction), was resuspended in homogenization buffer. For TxP experiments, the P2 was resuspended in homogenization buffer (lacking sucrose) containing 0.5% Triton X-100, homogenized with a rotating plastic pestle, incubated on ice for 40 min, and then spun at 32,000 ϫ g for 20 min. The pellet from this spin, TxP, was resuspended in homogenization buffer. The supernatant from this spin was subjected to acetone precipitation to concentrate the protein. Eight volumes of acetone were added to the supernatant, which was then incubated at Ϫ20°C overnight. The precipitate was collected by centrifugation at 3000 ϫ g for 15 min. The pellet from this spin, extrasynaptic membrane-enriched fraction (TxS), was dried and then resuspended in homogenization buffer. The supernatant from the second spin (S2) was spun at 100,000 ϫ g for 1 h. The pellet from this spin, microsome/light membrane-enriched fraction (P3), was resuspended in homogenization buffer. All of the above spins were conducted at 4°C to inhibit enzyme action. The final pellets were sonicated and boiled in 1% SDS, 1 mM EDTA, and 10 mM Tris (pH 8) for 5 min and kept at Ϫ80°C. We have previously characterized these fractionation procedures (36, 37) .
Cross-linking-For cross-linking experiments, each n represents all of the minislices that could be harvested from one animal divided equally between control un-X-linked (un-crosslinked), control X-linked (cross-linked), cLTD un-X-linked, and cLTD X-linked conditions. Minislices were harvested 45 min after the treatment into ice-cold ACSF (for un-X-linked) or ACSF containing 1 mg/ml bis(sulfosuccinimidyl) suberate (BS 3 ) (for X-linked). Minislices were then incubated on ice while rocking for 40 min. Following 40 min, the cross-linking reaction was quenched by three washes with ice-cold ACSF containing 20 mM Tris (pH 7.6). The minislices were then sonicated and boiled in 1% SDS, 1 mM EDTA, and 10 mM Tris (pH 8) for 5 min and kept at Ϫ80°C. To determine changes in the amount of internal receptor, cross-linked samples were directly compared. To determine changes in the percentage of surface expression, the following equation was used:
Semiquantitative Western Blotting-Protein concentrations were determined using the BCA TM protein assay kit from Pierce with bovine serum albumin (BSA) as a standard. Samples were prepared for gel loading such that they contained a known amount of total protein and 1ϫ SDS-PAGE sample buffer (62.5 mM Tris, 2% SDS, 10% glycerol, bromphenol blue, and 5% ␤-mercaptoethanol). A five-point standard curve of known total protein concentration was prepared as above from SDS-homogenized recovered whole hippocampal slices. The samples, along with the standard curve, were run through 7.5% polyacrylamide gels at 150 -200 V for 45-60 min. Separated proteins were transferred to PolyScreen polyvinylidene difluoride membranes. Blots were then blocked in 5% milk or 3% BSA in Tris-buffered saline with Tween (TBST: 140 mM NaCl, 20 mM Tris (pH 7.6), 0.1% Tween 20) for 1 h and then incubated overnight at 4°C with primary antibody in 1% milk or 1% BSA. Following three 10-min washes in TBST, blots were incubated in secondary antibody conjugated to horseradish peroxidase in 1% milk or 1% BSA at room temperature for 1 h. After three 10-min washes in TBST, bands were detected using Pierce SuperSignal chemiluminescence kits and the Alpha Innotech ChemiImager 4400 imaging system. In some cases, blots were stripped with Restore TM Western blot stripping buffer from Pierce for 60 min at 60°C, and then subjected to six 10-min washes in TBST followed by blocking and antibody incubation. Primary antibodies were as follows: GluR1 and GluR2/3 (Chemicon) used at 1:3000 in BSA, phospho-Ser-845 and phospho-Ser-831 (PhosphoSolutions) used at 1:1000 in BSA, PP2A␣ (BD Pharmingen) used at 1:5000 in milk, synapsin, NR2B, and NR1 (PhosphoSolutions) used at 1:2000 in BSA, the ␣ subunit of calcium/calmodulin-dependent protein kinase II (␣CaMKII) (BD Pharmingen) used at 1:3000 in BSA, phospho-Thr-286 (PhosphoSolutions) used at 1:3000 in milk, PSD-95 (Affinity Bioreagents) used at 1:5000 in BSA, and transferrin receptor (Zymed Laboratories Inc.) used at 1:1000 in milk.
Western Blot Analysis-Quantitation of Western blots was performed using AlphaEase software. An integrated density value for samples and standards was determined as the sum of the intensity of the pixels constituting each band. A line was generated from the standard curve by plotting the integrated density value versus the total amount of protein loaded for each curve point. Using this line, the integrated density value of each sample was used to calculate its immunoreactivity, which was measured in arbitrary immunoreactive (AIR) units. This number was then divided by the amount of total protein loaded in micrograms for the sample to obtain the AIR units/g. The AIR units/g is a measure of relative concentration that can be compared between samples. Relative phospho-stoichiometry was calculated by dividing the AIR units/g determined with the phospho-specific antibody by the AIR units/g determined with the pan antibody. To calculate total AIR units in the fractions, the AIR units/g value was multiplied by the total protein concentration of the fraction and by the total volume of the fraction. The percentage of total GluR1 and GluR2/3 in the fractions (reported in Fig. 5, B and D) was calculated by dividing the total AIR units value for a particular fraction by the summation of the total AIR units for the three fractions (making this summation 100%). Only samples with an integrated density value within the standard curve were used for analysis.
RESULTS
Long term depression was first described following an LFS paradigm (1), and LFS remains the most common method to induce LTD in hippocampal slices. However, stimulation by a single electrode only affects a limited region of the slice (38) , and therefore, it is problematic to measure biochemical changes in the entire slice following LFS-induced depression. Because of this, many researchers have turned to inducing LTD by chemical means, which, in theory, should activate virtually all of the synapses in the slice. It has been well established that brief application of NMDA results in synaptic depression in hippocampal slices (2, 9, 30, 39, 40) . Here we confirm that a 3-min, 20 M NMDA treatment (cLTD) induces a stable, long-lasting depression of the fEPSP recorded in the dendritic layer of CA1 minislices from P21-P29 rats (Fig. 1 ). As has been described previously, the synaptic response initially completely disappeared and then returned to a depressed level. Both the amplitude (Fig. 1B) and the initial slope (Fig.  1C) of the fEPSP were significantly depressed 45 min following the termination of the treatment (78.7 and 78.8% of baseline, respectively). All of the following biochemical experiments were performed at this time point, because here the synaptic response had stabilized.
We wanted to examine molecular mechanisms that might account for this stable synaptic depression. Because many stud-FIGURE 2. Neither GluR1 nor GluR2/3 total surface expression is changed 45 min following cLTD treatment, as determined by cross-linking assay. A, representative blots of X-linked (25.0 g of total protein loaded) and un-X-linked (5.0 g of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B, representative blots of un-X-linked and X-linked (5.0 g of total protein loaded for both) samples probed with antibodies specific for PP2A␣ (top bands) and synapsin (bottom bands). C and D, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (C) and GluR2/3 (D) (n ϭ 8). E and F, data from C and D normalized to the transferrin receptor. G and H, graphs of cumulative data comparing the percent surface expression (see "Experimental Procedures" for explanation of calculation) between control and cLTD conditions for GluR1 (G) and GluR2/3 (H) (n ϭ 8). I and J, graphs of cumulative data comparing un-X-linked and X-linked samples probed with antibodies specific for PP2A␣ (I) and synapsin (J) (n ϭ 8). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean Ϯ S.E.
ies have suggested that certain forms of synaptic depression are associated with a net internalization of AMPARs (see the Introduction), we initially assayed for changes in total surface membrane expression of these receptors. This was achieved by two independent measures. The first of these was a cross-linking assay using the covalent cross-linker BS 3 . This method has previously been used by ourselves and others to measure changes in receptor plasma membrane expression (11, (41) (42) (43) . Briefly, intact minislices were placed in ice-cold ACSF containing BS 3 and incubated on ice (to inhibit receptor exocytosis and endocytosis) for 40 min. The membrane-impermeable BS 3 works by covalently tethering all accessible receptors, in other words, receptors at the plasma membrane, leaving internal receptors untethered. Following the incubation, the minislices were homogenized in SDS and prepared for gel loading. Since the cross-linking is through a covalent mechanism, plasma membrane receptors stay tethered to each other following SDS homogenization. Because of this, when run on a polyacrylamide gel, only receptors that are not cross-linked run at the proper molecular weight. Thus, if a treatment leads to a net AMPAR internalization, more cross-link-resistant receptors should be recovered. Forty-five min following the cLTD treatment, there was no change in the amount of cross-link-resistant GluR1 (Fig. 2, A and C) or GluR2/3 (Fig. 2, A and D) , suggesting that there was no change in the amount of internal receptors. The data are also reported normalized to the transferrin receptor, a plasma membrane receptor that was not expected to change following the treatment (Fig. 2, E and F) . Concurrently, since there was no change in the concentration of the subunits in the homogenate (un-X-linked), there was no change in the percentage of GluR1 (Fig. 2, A and G) or GluR2/3 (Fig. 2, A and H) at the plasma membrane. Similar results were obtained at 15 min following the cessation of the treatment (data not shown). As a control to verify that the BS 3 was not crossing the plasma membrane and tethering intracellular proteins, we analyzed the effect of the cross-linker on synapsin and PP2A␣, two proteins that are expressed strictly intracellularly. The addition of BS 3 to minislices did not significantly alter the amount of protein that ran at the correct molecular weight for either protein, suggesting that the cross-linker did not cross the plasma membrane (Fig. 2, B, I , and J). To ensure that subtle differences between the experimental setups used for the electrophysiology and cross-linking experiments did not create artifactual biochemical differences, we repeated the above cross-linking experiment in the same setup used for the electrophysiology experiments. We observed similar results, confirming that there were no differences in cLTD effects on AMPAR surface expression between these two experimental systems (Fig. 3) .
All biochemical assays are subject to artifacts, and therefore, we sought to confirm the findings of the cross-linking experiment with another assay. As another measure of total surface FIGURE 3. Performing cross-linking assay following cLTD in the submersion setup does not produce different results than in the interface setup. A, representative blots of X-linked (25.0 g of total protein loaded) and un-X-linked (4.5 g of total protein loaded) samples for control and cLTD conditions probed with antibodies specific for GluR1 (left group) and GluR2/3 (right group). B and C, graphs of cumulative data comparing X-linked control and X-linked cLTD samples probed with antibodies specific for GluR1 (B) and GluR2/3 (C) (n ϭ 4). D and E, data from B and C normalized to the transferrin receptor. F and G, graphs of cumulative data comparing the percent surface expression (see "Experimental Procedures" for explanation of calculation) between control and cLTD conditions for GluR1 (F) and GluR2/3 (G) (n ϭ 4). No significant differences were observed for any of the comparisons as determined by Student's paired t test. Values represent the mean Ϯ S.E.
AMPAR expression, we examined GluR1 and GluR2/3 expression in a plasma membrane fraction that was obtained by differential centrifugation. Briefly, a crude synaptosomal membrane fraction was hypo-osmotically lysed to clear it of intracellular membranous organelles not associated with the plasma membrane. The resulting fraction, LP1, is known to be enriched in receptors that are expressed at the plasma membrane and has been previously characterized (37) . Forty-five min following the cessation of the treatment, there was no significant difference in the relative concentration of GluR1 (Fig.  4A ) or GluR2/3 (Fig. 4C) in the LP1 between control and cLTD conditions. The data are also reported normalized to the transferrin receptor (Fig. 4, B and D) . Similar to the previous crosslinking assay, this result suggests that the cLTD treatment did not result in a net internalization of AMPARs.
Both of the previous assays are measures of total surface/ plasma membrane expression of AMPARs. It is possible that these assays failed to detect a change in AMPAR localization because it was confined to the synaptic pool of receptors. Furthermore, another theoretical mechanism for the depression of synaptic responses is the trafficking of receptors from the synapse to extrasynaptic sites within the plasma membrane. Such a change would not be detected by measures of total plasma membrane expression. Therefore, we also analyzed AMPAR expression in the synaptic and extrasynaptic pools. A classical subcellular fractionation approach (33) (34) (35) was modified to obtain fractions from the minislices enriched for synaptic and extrasynaptic membranes (36) . This method capitalizes on the fact that PSDs and synaptic junctions are insoluble in Triton X-100 (44, 45) . Briefly, the crude synaptosomal membrane fraction (from above) was resuspended in a buffer containing 0.5% Triton X-100, incubated on ice for 40 min, and then spun at 32,000 ϫ g. We operationally defined the resulting pellet (TxP) as the synaptic membrane-enriched fraction and the supernatant (TxS) as the extrasynaptic membrane-enriched fraction. While performing these experiments, we also collected a microsome/light membrane-enriched fraction (here termed P3). We have previously characterized this fractionation protocol and confirmed that, as expected, the vast majority of PSD-95 (a marker for the postsynaptic density) is found in the TxP and the majority of calnexin (a marker for the endoplasmic reticulum) is found in the P3 (36). When we analyzed AMPAR expression in these fractions 45 min following the cLTD treatment, we observed a surprising result. The synaptic depression was actually correlated with a statistically significant increase in both GluR1 and GluR2/3 relative concentration in the TxP (34 and 25%, respectively) (Fig. 5, A and C) . There were no statistically significant changes in GluR1 or GluR2/3 relative concentration in the P3 or TxS fractions, suggesting that the source for the increase in the synaptic fraction was likely not in the extrasynaptic or microsomal fractions. Also shown is the percentage of total (summation of the three fractions) GluR1 and GluR2/3 that exists in each of the fractions (Fig. 5, B and D) .
We next wanted to determine whether this increase in AMPAR relative concentration in the synaptic fraction was specific or whether other proteins also showed a similar increase. The relative TxP concentration was measured for four other synaptically localized proteins: the NMDA receptor subunits NR2B and NR1, ␣CaMKII, and PSD-95 (Fig. 5E ). There was a small (12%) but statistically significant increase in ␣CaMKII. Both NR2B and PSD-95 also demonstrated small increases (17 and 15%, respectively); however, these changes failed to reach statistical significance. In contrast, there was no change in the relative TxP concentration of NR1. It is possible that the increase in TxP concentration of these proteins partially reflects the redistribution of other proteins away from the synapse following cLTD induction. This has been demonstrated for A-kinase anchoring protein (AKAP)79/150 and protein kinase A (11). Nevertheless, we found no evidence for a decrease in the concentration of AMPARs at the synapse.
The above data demonstrate that the NMDA-induced depression was not correlated with internalization of AMPARs in our hands. As discussed in the Introduction, the other main mechanism for the postsynaptic modification of glutamate receptor responses is through alterations in their functional properties. Indeed, Ser-845 phosphorylation has been demonstrated to control AMPAR peak open probability (17) , and several forms of synaptic depression have been shown to be corre- lated with a decrease in phosphorylation of this site (2, 8, 11, 13, 14) . We therefore examined the relative Ser-845 phospho-stoichiometry in the neuronal fractions from control and cLTD-treated minislices. We found that 45 min after the cLTD treatment, phosphorylation of this residue was significantly decreased in the TxP, TxS, and P3 (Ϫ33, Ϫ31, and Ϫ19%, respectively) (Fig. 6A) . This persistent decrease in Ser-845 phosphorylation contrasts with the transient NMDA-induced Ser-845 dephosphorylation seen in cultured neurons (14) . Another phosphorylation site on GluR1 that influences AMPAR function is serine 831 (Ser-831). Phosphorylation of this residue controls the single-channel conductance of AMPARs (46) . Forty-five min after the cLTD treatment, we observed a significant decrease in Ser-831 phospho-stoichiometry in the TxP (22%) with no significant change in the TxS or P3 (Fig. 6B) . Several previous studies have found that LTD-inducing treatments do not lead to changes in Ser-831 phosphorylation (2, 8, 11, 13, 14) . The discrepancy may be due to the fact that the dephosphorylation was restricted to the synaptic fraction, and indeed, we did not observe Ser-831 dephosphorylation in the homogenate (data not shown). There were no changes in ␣CaMKII Thr-286 phospho-stoichiometry in any of the fractions, suggesting that the dephosphorylation of GluR1 in the synaptic fraction was relatively specific for this protein (data not shown). A, left, representative blots of TxP (3.3 g of total protein loaded), TxS (6.5 g loaded), and P3 (6.0 g loaded) samples for control and cLTD conditions probed with an antibody specific for GluR1. Right, graph of cumulative data comparing relative GluR1 concentration between control and cLTD conditions for TxP (n ϭ 10), TxS (n ϭ 6), and P3 (n ϭ 10) fractions. Bonferroni's post hoc analysis indicated a significant increase in the TxP (**, p Ͻ 0.01). B, data from A recalculated to demonstrate the percentage of total GluR1 present in each of the fractions (see "Experimental Procedures" for explanation of calculation). C, left, representative blots of TxP (3.0 g of total protein loaded), TxS (6.5 g loaded), and P3 (6.0 g loaded) samples for control and cLTD conditions probed with an antibody specific for GluR2/3. Right, graph of cumulative data comparing relative GluR2/3 concentration between control and cLTD conditions for TxP (n ϭ 10), TxS (n ϭ 6), and P3 (n ϭ 9) fractions. Bonferroni's post hoc analysis indicated a significant increase in the TxP (**, p Ͻ 0.01). D, data from C recalculated to demonstrate the percentage of total GluR2/3 present in each of the fractions. E, left, representative blots of TxP samples for control and cLTD conditions probed with antibodies specific for NR2B (1.3 g of total protein loaded), NR1 (1.3 g loaded), ␣CaMKII (3.0 g loaded), and PSD-95 (1.3 g loaded). Right, graph of cumulative data comparing relative NR2B (n ϭ 10), NR1 (n ϭ 9), ␣CaMKII (n ϭ 10), and PSD-95 (n ϭ 10) concentration between control and cLTD conditions for the TxP fraction. Only ␣CaMKII was significantly increased (*, p Ͻ 0.05) as determined by Student's paired t test. Values represent the mean Ϯ S.E.
DISCUSSION
In this study, we sought to determine the molecular mechanisms that underlie chemically induced synaptic depression in area CA1 of the hippocampus. As has been seen by others, a 3-min, 20 M NMDA treatment led to a stable depression of the fEPSP (cLTD) in our experimental system. This synaptic depression persisted for at least 60 min following cessation of the NMDA infusion. Utilizing three assays of AMPAR localization, we found no evidence for internalization 45 min after the induction of cLTD. In contrast, the relative phospho-stoichiometry of GluR1 Ser-845 was significantly and persistently decreased in several subcellular compartments, including the synaptic fraction. Also, the relative phosphostoichiometry of GluR1 Ser-831 was decreased in the synaptic fraction. These data led us to the conclusions that it is possible for synaptic depression to occur in the absence of decreases in synaptic AMPAR number and that a functional change of synaptic AMPARs is likely sufficient for stable long term depression. However, there are possible alternative mechanisms to account for the depression that were not analyzed in this study. Among these are dephosphorylation of GluR1 Thr-840 (40) and potentiation of inhibitory transmission (47) . Furthermore, it is important to take into consideration the fact that this chemically induced LTD differs from electrically induced NMDAR-dependent LTD. While electrically induced LTD is likely mediated by activation of only synaptic NMDARs, the bath application of NMDA used here likely activates both synaptic and extrasynaptic NMDARs.
Many of the studies that have measured AMPAR localization/trafficking in correlation with NMDA-induced LTD have been performed in cultured neurons. One possible explanation for why these studies observed AMPAR internalization and we did not is that cultured neurons are prepared from embryonic tissue and are assayed at times that correspond with synaptogenesis (48) . AMPARs are known to be very mobile during this developmental stage. In contrast, our minislices were made from 21-29-day-old rats, a time period after the majority of synaptogenesis has occurred (48) . It is possible that the differences between our results and those obtained from cultured neurons reflect developmental differences in the mechanisms underlying LTD. There are also reports of NMDA-induced AMPAR internalization in acute hippocampal slices from P21ϩ rats (11, 30, 31) . Although the discrepancy between our findings and these reports is surprising, it is important to note that in the one study of these that measured synaptic responses, the degree of depression was almost double that which we observed in this study (30) . It is conceivable that a reduction in surface AMPARs is additive to the effect that we see here (namely a decrease in Ser-845 and Ser-831 phosphorylation at the synapse) and that this accounts for the greater amount of depression that they reported.
Another surprising result in this study was that a reduction in Ser-845 phosphorylation did not lead to a reduction in surface AMPARs. As stated in the Introduction, several studies have suggested that phosphorylation of this residue controls the synaptic localization of the receptor. However, there have also been observations that suggest the scenario is more complicated than this. In neurons in which Ser-845 has been mutated to an alanine and thus cannot be phosphorylated, the localization of the mutant GluR1 is similar to that of wild-type GluR1 (15, 24) . If Ser-845 phosphorylation was required for synaptic localization of AMPARs, one would expect differences in the distribution of receptors that cannot be phosphorylated on this site. Furthermore, although Oh et al. (25) observed a correlation between changes in Ser-845 phosphorylation and surface expression of GluR1, they also observed that the Ser-845 phosphorylation stoichiometry did not differ between the surface and total GluR1 fractions. This would not be expected if Ser-845 phosphorylation was a dominant mechanism controlling GluR1 localization. Similar results were obtained in this study (Fig. 6A) . In our synaptic fraction, relative Ser-845 phosphostoichiometry was actually lower than in the extrasynaptic and microsomal fractions.
The presence of mechanistically distinct modes of AMPAR modification has been established for long term potentiation. It has been demonstrated that, in some cases, potentiation is correlated with AMPAR trafficking to the synapse (49) . Long term potentiation has also been demonstrated to be correlated with an increase in single-channel conductance of AMPARs, and this modification of functional properties can be sufficient to account for potentiation (50) . It appears that phosphorylation FIGURE 6 . cLTD (45 min following termination of treatment) is correlated with a decrease in GluR1 Ser-845 relative phospho-stoichiometry throughout the neuron and a decrease in GluR1 Ser-831 phospho-stoichiometry in the synaptic fraction. A, left, representative blots of TxP (7.7 g of total protein loaded control, 6.4 g of cLTD), TxS (7.5 g loaded, both conditions), and P3 (7.7 g of loaded control, 7.1 g of cLTD) samples for control and cLTD conditions probed with an antibody specific for Ser-845 phosphorylated GluR1. Right, graph of cumulative data comparing relative Ser-845 phospho-stoichiometry (see "Experimental Procedures" for explanation of calculation) between control and cLTD conditions for TxP (n ϭ 10), TxS (n ϭ 6), and P3 (n ϭ 10) fractions. Bonferroni's post hoc analysis indicated significant decreases in the TxP (#, p Ͻ 0.001), TxS (*, p Ͻ 0.05), and P3 (**, p Ͻ 0.01). B, left, representative blots of TxP (3.0 g of total protein loaded), TxS (8.0 g loaded), and P3 (6.0 g loaded) samples for control and cLTD conditions probed with an antibody specific for Ser-831 phosphorylated GluR1. Right, graph of cumulative data comparing relative Ser-831 phospho-stoichiometry between control and cLTD conditions for TxP (n ϭ 10), TxS (n ϭ 6), and P3 (n ϭ 10) fractions. Bonferroni's post hoc analysis indicated a significant decrease in the TxP (**, p Ͻ 0.01). Values represent the mean Ϯ S.E.
of Ser-831 on GluR1 is responsible for this change because Ser-831 phosphorylation is increased following long term potentiation induction (51, 52) , and phosphorylation of this residue is known to enhance AMPAR conductance in a heterologous cell system (46) . Here we argue that a similar scenario may exist for LTD. Depression can be achieved through AMPAR internalization, a change in functional properties (mediated by a decrease in Ser-845 and, to a lesser extent, Ser-831 phosphorylation), or a combination of both. In this study, we have demonstrated that a decrease in GluR1 phosphorylation can occur independently of AMPAR internalization, and therefore, it is likely that, in certain cases, a decrease in AMPAR function may be sufficient to account for synaptic depression.
